| Autor: |
Klimek M; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., Ebstein E; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., Gaudemer A; Service de Radiologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., Deconinck L; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., de Ponfilly MP; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., Benattar L; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., Ottaviani S; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., Forien M; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France., Dieudé P; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France; INSERM UMR 1152, Université de Paris, Paris, France., Juge PA; Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France; Center for Research in Epidemiology and Statistics, INSERM UMR 1153, Université Paris Cité, Paris, France. Electronic address: pierreantoine.juge@aphp.fr. |
| Abstrakt: |
Competing Interests: Declaration of interests PD reports grants from Bristol Myers Squibb, Pfizer, and Boehringer Ingelheim; and honoraria from Bristol Myers Squibb, Lilly, Pfizer, Medac, Novartis, UCB Pharma, Boehringer Ingelheim, and AbbVie, all outside this work. P-AJ reports grants from Novartis and the Société Française de Rhumatologie, consulting fees from Galapagos, and honoraria for lectures from Boehringer Ingelheim and Novartis, all outside this work. All other authors declare no competing interests. |
